Qualitative differences in disease-associated MEK mutants reveal molecular signatures and aberrant signaling-crosstalk in cancer

Point-mutations of MEK1, a central component of ERK signaling, are present in cancer and RASopathies, but their precise biological effects remain obscure. Here, we report a mutant MEK1 structure that uncovers the mechanisms underlying abnormal activities of cancer- and RASopathy-associated MEK1 muta...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubota, Yuji, Fujioka, Yuko, Patil, Ashwini, Takagi, Yusuke, Matsubara, Daisuke, Iijima, Masatomi, Momose, Isao, Naka, Ryosuke, Nakai, Kenta, Noda, Nobuo N., Takekawa, Mutsuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279491/
https://www.ncbi.nlm.nih.gov/pubmed/35831322
http://dx.doi.org/10.1038/s41467-022-31690-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279491/
https://www.ncbi.nlm.nih.gov/pubmed/35831322
http://dx.doi.org/10.1038/s41467-022-31690-w

Ejemplares similares